Evidence map›Paper›PMID 42038657›Full record

ArticleClinical case reports2026

Acute Systemic Complications Following High-Dose Semaglutide Reinitiation in an Elderly Patient.

Jay Mehta, Brent Tai, Johnathan Frunzi

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jay MehtaInternal Medicine Residency Program BayCare Health/Mease Countryside Hospital Safety Harbor Florida USA.ORCID https://orcid.org/0009-0005-4141-5370
Brent TaiInternal Medicine Residency Program BayCare Health/Mease Countryside Hospital Safety Harbor Florida USA.
Johnathan FrunziInternal Medicine Residency Program BayCare Health/Mease Countryside Hospital Safety Harbor Florida USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe gastrointestinal intolerance with systemic complications can occur within hours of reinitiating high-dose semaglutide after a prolonged treatment interruption, even in patients who previously tolerated the medication. Elderly patients with comorbidities may be particularly vulnerable. Clinicians should consider re-titration from lower doses when restarting GLP-1 receptor agonists after drug holidays to minimize severe adverse effects.

Indexed as

drug holidaydrug‐related side effects and adverse reactionselderlyesophagitisglucagon‐like peptide‐1 receptor agonistshypertensive urgencysemaglutide

Identifiers

PMID42038657
PMCPMC13106220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.